Linear B cell epitope prediction for epitope vaccine design against meningococcal disease and their computational validations through physicochemical properties

[1]  T. Khoshgoftaar,et al.  Threshold-based feature selection techniques for high-dimensional bioinformatics data , 2012, Network Modeling Analysis in Health Informatics and Bioinformatics.

[2]  Yin-Fu Huang,et al.  An exon/intron disparity framework based on the nucleotide profile of single sequence , 2012, Network Modeling Analysis in Health Informatics and Bioinformatics.

[3]  N. Rouphael,et al.  Neisseria meningitidis: biology, microbiology, and epidemiology. , 2012, Methods in molecular biology.

[4]  T. Singh,et al.  Comparative analysis of epitope predictions: proposed library of putative vaccine candidates for HIV , 2011, Bioinformation.

[5]  T. Singh,et al.  Prediction and characterization of T-cell epitopes for epitope vaccine design from outer membrane protein of Neisseria meningitidis serogroup B , 2010, Bioinformation.

[6]  Alessandro Sette,et al.  The Immune Epitope Database 2.0 , 2009, Nucleic Acids Res..

[7]  Itay Mayrose,et al.  Epitopia: a web-server for predicting B-cell epitopes , 2009, BMC Bioinformatics.

[8]  Nimrod D. Rubinstein,et al.  A machine-learning approach for predicting B-cell epitopes. , 2009, Molecular immunology.

[9]  Nimrod D. Rubinstein,et al.  Computational characterization of B-cell epitopes. , 2008, Molecular immunology.

[10]  O. Lund,et al.  Prediction and Identification of B Cell Epitopes Using Protein Sequence and Structure Information , 2008 .

[11]  P. Skipp,et al.  Proteomic Analysis of Outer Membranes and Vesicles from Wild-Type Serogroup B Neisseria meningitidis and a Lipopolysaccharide-Deficient Mutant , 2006, Infection and Immunity.

[12]  P. Offit,et al.  The meningococcal vaccine--public policy and individual choices. , 2003, The New England journal of medicine.

[13]  Christopher T. Saunders,et al.  Evaluation of structural and evolutionary contributions to deleterious mutation prediction. , 2002, Journal of molecular biology.

[14]  I. Feavers,et al.  Development of vaccines against meningococcal disease , 2002, The Lancet.

[15]  A. Pollard,et al.  Vaccine prevention of meningococcal disease, coming soon? , 2001, Vaccine.

[16]  Huan‐Xiang Zhou,et al.  Prediction of protein interaction sites from sequence profile and residue neighbor list , 2001, Proteins.

[17]  Jamie K. Scott,et al.  Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics , 2001, Current Opinion in Chemical Biology.

[18]  Frank C. Hay,et al.  Epitope mapping : a practical approach , 2000 .

[19]  R M Jackson,et al.  Comparison of protein–protein interactions in serine protease‐inhibitor and antibody‐antigen complexes: Implications for the protein docking problem , 2008, Protein science : a publication of the Protein Society.

[20]  C. Chothia,et al.  The atomic structure of protein-protein recognition sites. , 1999, Journal of molecular biology.

[21]  R D Appel,et al.  Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.

[22]  A. Bogan,et al.  Anatomy of hot spots in protein interfaces. , 1998, Journal of molecular biology.

[23]  M. V. Regenmortel,et al.  Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity , 1996 .

[24]  Van Regenmortel MHV.  Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity , 1996, Methods.

[25]  J M Thornton,et al.  Protein-protein interactions: a review of protein dimer structures. , 1995, Progress in biophysics and molecular biology.

[26]  E Westhof,et al.  Predicting location of continuous epitopes in proteins from their primary structures. , 1991, Methods in enzymology.

[27]  R. Lerner,et al.  Mobility and evolutionary variability factors in protein antigenicity (reply) , 1985, Nature.

[28]  R. Jemmerson,et al.  Mobility and evolutionary variability factors in protein antigenicity , 1985, Nature.

[29]  M. Leinonen,et al.  ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS Implications for Vaccine Development and Pathogenesis , 1983, The Lancet.

[30]  C. Cordova,et al.  TYPE-III HYPERUPOPROTEINÆMIA , 1977, The Lancet.